Use of psychotropic drugs during pregnancy F. MarchettiM. RomeroCollaborative Group on Drug Use in Pregnancy (CGDUP) Originals Pages: 495 - 501
Effect of intravenous dopamine on blood pressure and plasma insulin in hypertensive patients G. MartinP. ForteM. Velasco Originals Pages: 503 - 505
The consequences of H2 receptor antagonist — piroxicam coadministration in patients with joint disorders P. A. MilliganP. E. McGillB. Whiting Originals Pages: 507 - 512
Efficacy and safety of high dose fluvastatin in patients with familial hypercholesterolaemia E. LeitersdorfS. EisenbergY. Stein Originals Pages: 513 - 518
Plasma levels of piperacillin and vancomycin used as prophylaxis in liver transplant patients M. DuponG. JanvierJ. Saric Originals Pages: 529 - 534
Comparison of parameters of in vitro lymphocyte β2-adrenoceptor function in normal and asthmatic subjects D. M. NewnhamW. J. R. CoutieB. J. Lipworth Originals Pages: 535 - 538
Central effects of combined bendrofluazide and atenolol administration L. GerrardN. M. WheeldonD. G. McDevitt Originals Pages: 539 - 543
Pharmacokinetic model identification and parameter estimation as an ill-posed problem H. SchwildenJ. HonerkampC. Elster Originals Pages: 545 - 550
The effect of probenecid on paracetamol metabolism and pharmacokinetics F. Kamali Originals Pages: 551 - 553
Pharmacokinetics of intranasal, intramuscular and intravenous glucagon in healthy subjects and diabetic patients A. E. PontiroliA. CalderaraS. R. Bareggi Originals Pages: 555 - 558
The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis W. C. ShyuK. A. PittmanR. H. Barbhaiya Originals Pages: 559 - 562
Pharmacokinetics of chlorpromazine and key metabolites P. K. -F. YeungJ. W. HubbardK. K. Midha Originals Pages: 563 - 569
Lack of influence of short-term treatment with propranolol and terbutaline on metabolism and energy expenditure of the Na-K pump in human erythrocytes evaluated by microcalorimetry B. FagherH. LiedholmM. Monti Originals Pages: 571 - 576
Protein binding of digitoxin, valproate and phenytoin in sera from diabetics J. DoucetJ. FreselN. Moore Short Communications Pages: 577 - 579
Pharmacodynamic modeling of cortisol suppression from fluocortolone K. H. LewW. J. Jusko Short Communications Pages: 581 - 583
